Therapeutic Prospects for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-vitro Evidence and Pharmacokinetic Profile

Vatsalya Vatsalya, Fengyuan Li, Jane Frimodig, Khushboo S. Gala, Shweta Srivastava, Maiying Kong, Vijay A Ramchandani, Wenke Feng, Xiang Zhang, Craig J McClain
doi: https://doi.org/10.1101/2020.08.23.20177501

Article usage

Article usage: August 2020 to March 2023

AbstractFullPdf
Aug 20208690159
Sep 202012100405
Oct 20203930176
Nov 20203670121
Dec 2020214084
Jan 2021308092
Feb 2021230363
Mar 20212642968
Apr 20212527496
May 2021192656
Jun 20212491259
Jul 2021147646
Aug 2021145959
Sep 2021345152
Oct 20212732157
Nov 2021150551
Dec 20211461130
Jan 20221081543
Feb 202296319
Mar 202259529
Apr 202287024
May 202292434
Jun 202257113
Jul 202247011
Aug 202268720
Sep 202273023
Oct 202270526
Nov 202249210
Dec 202266121
Jan 202375221
Feb 202365334
Mar 202351113
Back to top
Posted August 25, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Therapeutic Prospects for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-vitro Evidence and Pharmacokinetic Profile
Vatsalya Vatsalya, Fengyuan Li, Jane Frimodig, Khushboo S. Gala, Shweta Srivastava, Maiying Kong, Vijay A Ramchandani, Wenke Feng, Xiang Zhang, Craig J McClain
medRxiv 2020.08.23.20177501; doi: https://doi.org/10.1101/2020.08.23.20177501
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area